These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 33756448)

  • 1. Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma.
    Nguyen R; Goodell JC; Shankarappa PS; Zimmerman S; Yin T; Peer CJ; Figg WD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1171():122641. PubMed ID: 33756448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies.
    Xiao D; John Ling KH; Tarnowski T; Humeniuk R; German P; Mathias A; Chu J; Chen YS; van Ingen E
    Anal Biochem; 2021 Mar; 617():114118. PubMed ID: 33508271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient.
    Alvarez JC; Moine P; Etting I; Annane D; Larabi IA
    Clin Chem Lab Med; 2020 Aug; 58(9):1461-1468. PubMed ID: 32573468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat.
    Du P; Wang G; Yang S; Li P; Liu L
    Anal Bioanal Chem; 2021 Sep; 413(23):5811-5820. PubMed ID: 34302183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.
    Avataneo V; de Nicolò A; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A
    J Antimicrob Chemother; 2020 Jul; 75(7):1772-1777. PubMed ID: 32361744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
    Habler K; Brügel M; Teupser D; Liebchen U; Scharf C; Schönermarck U; Vogeser M; Paal M
    J Pharm Biomed Anal; 2021 Mar; 196():113935. PubMed ID: 33548872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of remdesivir and its nucleoside metabolite in beagle dogs and healthy humans by liquid chromatography coupled with triple quadrupole mass spectrometry.
    Dubey NK; Jain P; Raj A; Tiwari S
    Biomed Chromatogr; 2024 Oct; 38(10):e5965. PubMed ID: 39039650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of High-Performance Liquid Chromatography Method for the Quantification of Remdesivir in Intravenous Dosage Form.
    Jitta SR; Salwa ; Kumar L; Gangurde PK; Verma R
    Assay Drug Dev Technol; 2021; 19(8):475-483. PubMed ID: 34665025
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and validation of an LC-MS/MS method for simultaneous determination of remdesivir and its hydrolyzed metabolite and nucleoside, and its application in a pharmacokinetic study of normal and diabetic nephropathy mice.
    Yuan M; Hu W; Feng Y; Tong Y; Wang X; Tan B; Xu H; Liu J
    Biomed Chromatogr; 2022 Jul; 36(7):e5380. PubMed ID: 35373846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined assay for quantifying remdesivir and its metabolite, along with dexamethasone, in serum.
    Reckers A; Wu AHB; Ong CM; Gandhi M; Metcalfe J; Gerona R
    J Antimicrob Chemother; 2021 Jun; 76(7):1865-1873. PubMed ID: 33864090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a paper spray mass spectrometry method for the rapid quantitation of remdesivir and its active metabolite, GS-441524, in human plasma.
    Skaggs C; Zimmerman H; Manicke N; Kirkpatrick L
    J Mass Spectrom Adv Clin Lab; 2022 Aug; 25():27-35. PubMed ID: 35721272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry.
    Ma Z; Li S; He D; Wang Y; Jiang H; Zhou H; Jin J; Lin N
    Rapid Commun Mass Spectrom; 2020 May; 34(9):e8728. PubMed ID: 31960519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS.
    Hu W; Chang L; Ke C; Xie Y; Shen J; Tan B; Liu J
    J Pharm Biomed Anal; 2021 Feb; 194():113806. PubMed ID: 33280995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpatient variability in the pharmacokinetics of remdesivir and its main metabolite GS-441524 in treated COVID-19 subjects.
    Tempestilli M; Ascoli Bartoli T; Benvenuto D; Stazi GV; Marchioni L; Nicastri E; Agrati C
    J Antimicrob Chemother; 2022 Sep; 77(10):2683-2687. PubMed ID: 35848782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated stability study of the ester prodrug remdesivir: Recently FDA-approved Covid-19 antiviral using reversed-phase-HPLC with fluorimetric and diode array detection.
    Hamdy MMA; Abdel Moneim MM; Kamal MF
    Biomed Chromatogr; 2021 Dec; 35(12):e5212. PubMed ID: 34227154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a cost-effective and sensitive bioanalytical HPLC-UV method for determination of lopinavir in rat and human plasma.
    Qin C; Feng W; Chu Y; Lee JB; Berton M; Bettonte S; Teo YY; Stocks MJ; Fischer PM; Gershkovich P
    Biomed Chromatogr; 2020 Nov; 34(11):e4934. PubMed ID: 32598032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic.
    Pashaei Y
    Drug Discov Ther; 2021 Jan; 14(6):273-281. PubMed ID: 33390567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia.
    Corcione S; De Nicolò A; Montrucchio G; Scabini S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A
    Br J Clin Pharmacol; 2021 Dec; 87(12):4861-4867. PubMed ID: 33990984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
    Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
    PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.